Funder: National Institutes of Health
Due Dates: May 29, 2024 | January 28, 2025 | September 29, 2025 | May 28, 2026 | January 28, 2027 (all for New, Renewal, Resubmission, Revision)
Funding Amounts: Up to $750,000 direct costs per year, for up to 3 years; total program funding ~$8M/year for 5–7 awards.
Summary: Supports preclinical proof-of-concept and translational development of novel CNS recording and modulation technologies, advancing them toward readiness for first-in-human studies.
Key Information: Clinical trials are not allowed; limited submission—one application per institution per cycle.